Dopamine-induced apoptosis is inhibited in PC12 cells expressing Bcl-2

Cellular and Molecular Neurobiology

Volumn 17, Issue 3, 1997, Pages 289-304

  Offen, D ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Antioxidants; Apoptosis; Bcl 2; Dopamine; Dopamine melanin; Parkinson's disease

Indexed keywords

DNA FRAGMENT; DOPAMINE; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CHROMATIN CONDENSATION; CONTROLLED STUDY; DIAGNOSIS; DOPAMINE RELEASE; NEUROPROTECTION; NONHUMAN; OXIDATION; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; RAT; SYMPATHETIC NERVE;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; CELL EXTRACTS; CELL SURVIVAL; CULTURE MEDIA, SERUM-FREE; DNA DAMAGE; DOPAMINE; IN SITU HYBRIDIZATION; MELANINS; MICE; PC12 CELLS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; SULFHYDRYL COMPOUNDS; THYMIDINE;

ANIMALIA; MAMMALIA;

EID: 0030965053     PISSN: 02724340     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026390201168     Document Type: Article

References (12)

1. Agid, Y. (1995). Aging, disease and nerve cell death. Bull. Acad. Natl. Med. 179:1193-1203.
2. Allsopp, T. E., Wyatt, S., Paterson, F. H., and Davies, A. M. (1993). The proto-oncogene Bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis. Cell 73:295-307.
3. Anderson, S., Davies, D. N., and Bahlback, H. (1989). Cloning structure and expression of the mitochondrial cytochrome p-450 sterol 6-hydroxylase, a bile acid biosynthetic enzyme. J. Biol. Chem. 264:8222-8229.
4. Bindoli, A., Rigobello, M. P., and Deeble, D. J. (1992). Biochemical and toxicological properties of the oxidation products of catecholamines. Free Radical Biol. Med. 13:391-405.
5. Cohen, G. (1983). The pathobiology of Parkinson's disease: Biochemical aspects of dopamine neuron senescence. J. Neural. Transm. Suppl.:89-103.
6. Damier, P. D., Zhang, H. P., Agid, Y., and Javoy-Agid, F. (1993). Glutathione peroxidase, glial cells and Parkinson's disease. Neuroscience 52:1-6.
7. Das, K. C., Abramson, M. B., and Katzman, R. (1978). Neuronal pigments: Spectroscopic characterization of human brain melanin. J. Neurochem. 30:601-605.
8. Dexter, D. T., Carter, C. J., Wells, F. R., Javoy-Agid, F., Agid, Y., Lees, A., Jenner, P., and Marsden, C. D. (1989). Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J. Neurochem. 52:381-389.
9. Garcia, I., Martinou, I., Tsujimoto, Y., and Martinou, J. (1992). Preventing of programmed cell death of sympathetic neurons by the Bcl-2 proto-oncogene. Science 258:302-304.
10. Gavrieli, Y., Sherman, Y., and Ben-Sasson, S. A. (1992). Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:493-500.
11. Graham, D. G. (1978). Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol. Pharmacol. 14:633-643.
12. Hockenbery, D., Zuttern, B., Hickey, W., Nahm, M., and Korsmeyer, S. J. (19991). BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc. Natl. Acad. Sci. USA 88:6961-6965.